<DOC>
	<DOCNO>NCT00883311</DOCNO>
	<brief_summary>The purpose study determine whether topical application BRT-FC-83C effective treatment mild moderate atopic dermatitis .</brief_summary>
	<brief_title>A Study BRT-FC-83C Treatment Atopic Dermatitis</brief_title>
	<detailed_description>Atopic dermatitis common skin disease . BRT-FC-83C skin cream contain corticosteroid anti-inflammatory component . It represent novel class skin barrier repair therapy chronic dermatosis . The objective clinical study determine whether BRT-FC-83C , applied twice day affect area skin , ameliorate sign symptom mild moderate atopic dermatitis .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Clinically verify mild moderate atopic dermatitis . Atopy diagnosis base clinical score 37.5 base Rajka Langeland criterion Men woman age 1850 year At least one mild moderate atopic lesion involve 20 % Body Surface Area ( BSA ) Active atopic dermatitis least 3 year Willingness cooperate participate follow study requirement Written inform consent Individuals actively ooze atopic lesion Individuals smoker Individuals insulindependent diabetes mellitus Individuals know pregnant , nursing , plan become pregnant within next six month enrollment Individuals currently participate another clinical usage study would interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Efficacy</keyword>
</DOC>